As of January 2026 BioMarin Pharmaceutical has a market cap of S$13.86 Billion. This makes BioMarin Pharmaceutical the world's 1901th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 14th, 2026 the market cap of BioMarin Pharmaceutical was reported to be: